Abstract Fibrocalculous pancreatic diabetes (FCPD) is a rare form of secondary diabetes in which there is insulin deficiency. The mainstay of treatment for FCPD is insulin. When insulin is delivered through basal bolus regime, there is a risk of hypo and hyperglycemic episodes if the dose is not adjusted properly. In this case, we report the journey of a patient with FCPD who was earlier on basal bolus insulin regime and later switched to the automated hybrid closed-loop 780G insulin pump, which significantly improved her quality of life.
Damle et al. (Fri,) studied this question.